These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 2881849

  • 21. Antioxidant properties of aminosalicylates.
    Miles AM, Grisham MB.
    Methods Enzymol; 1994; 234():555-72. PubMed ID: 7808332
    [No Abstract] [Full Text] [Related]

  • 22. Effect of 5-aminosalicylic acid (5-ASA) and other salicylates on short-chain fat metabolism in the colonic mucosa. Pharmacological implications for ulcerative colitis.
    Roediger W, Schapel G, Lawson M, Radcliffe B, Nance S.
    Biochem Pharmacol; 1986 Jan 15; 35(2):221-5. PubMed ID: 2867767
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of prostaglandin synthetase in human rectal mucosa.
    Hawkey CJ, Lo Casto M.
    Gut; 1983 Mar 15; 24(3):213-7. PubMed ID: 6131017
    [Abstract] [Full Text] [Related]

  • 24. [Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue].
    Wittenberg HR, Kleemeyer K, Peskar BM, Peskar BA.
    Wien Klin Wochenschr; 1991 Mar 15; 103(2):34-9. PubMed ID: 1673814
    [Abstract] [Full Text] [Related]

  • 25. Influence of sulfasalazine, 5-aminosalicylic acid and sulfapyridine on prostanoid synthesis and metabolism in rabbit colonic mucosa.
    Kolassa N, Becker R, Wiener H.
    Prostaglandins; 1985 Jan 15; 29(1):133-42. PubMed ID: 2858116
    [Abstract] [Full Text] [Related]

  • 26. Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation.
    Rachmilewitz D, Karmeli F, Schwartz LW, Simon PL.
    Gut; 1992 Jul 15; 33(7):929-32. PubMed ID: 1353743
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of neutral proteases from polymorphonuclear (PMN) neutrophils by salicylazosulfapyridine (SASP).
    Klessen C.
    Histochemistry; 1980 Jul 15; 66(1):43-7. PubMed ID: 6104653
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of red cell membrane lipid peroxidation by sulphasalazine and 5-aminosalicylic acid.
    Greenfield SM, Punchard NA, Thompson RP.
    Gut; 1991 Oct 15; 32(10):1156-9. PubMed ID: 1683330
    [Abstract] [Full Text] [Related]

  • 29. Effect of sulphasalazine and sulphapyridine on neutrophil superoxide production: role of cytosolic free calcium.
    Kanerud L, Hafström I, Ringertz B.
    Ann Rheum Dis; 1990 May 15; 49(5):296-300. PubMed ID: 1971506
    [Abstract] [Full Text] [Related]

  • 30. Increased suppressor cell activity in inflammatory bowel disease.
    Holdstock G, Chastenay BF, Krawitt EL.
    Gut; 1981 Dec 15; 22(12):1025-30. PubMed ID: 6119275
    [Abstract] [Full Text] [Related]

  • 31. Effect of antibiotics on the generation of reactive oxygen species.
    Miyachi Y, Yoshioka A, Imamura S, Niwa Y.
    J Invest Dermatol; 1986 Apr 15; 86(4):449-53. PubMed ID: 3755739
    [Abstract] [Full Text] [Related]

  • 32. Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine.
    Allgayer H, Eisenburg J, Paumgartner G.
    Eur J Clin Pharmacol; 1984 Apr 15; 26(4):449-51. PubMed ID: 6428914
    [Abstract] [Full Text] [Related]

  • 33. Sulphasalazine and derivatives, natural killer activity and ulcerative colitis.
    Gibson PR, Jewell DP.
    Clin Sci (Lond); 1985 Aug 15; 69(2):177-84. PubMed ID: 2866061
    [Abstract] [Full Text] [Related]

  • 34. Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.
    Kimura I, Kawasaki M, Nagahama S, Matsuda A, Kataoka M, Kokuba Y.
    Arzneimittelforschung; 1998 Nov 15; 48(11):1091-6. PubMed ID: 9850431
    [Abstract] [Full Text] [Related]

  • 35. The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis.
    Molin L, Stendahl O.
    Acta Med Scand; 1979 Nov 15; 206(6):451-7. PubMed ID: 43662
    [Abstract] [Full Text] [Related]

  • 36. Influence of sulphasalazine and mesalazine on cellular and biochemical oxygen metabolite production. Effect of in vivo administration and an in vitro analysis.
    Verspaget HW, Aparicio-Pagés MN, Verver S, Edelbroek PM, Hafkenscheid JC, Crama-Bohbouth GE, Peña AS, Weterman IT, Lamers CB.
    Scand J Gastroenterol; 1991 Jul 15; 26(7):779-86. PubMed ID: 1680247
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the effects of sulphasalazine, 5-aminosalicylic acid and sulphapyridine on the humoral response to antigen in vivo.
    Sheldon P, Pell P.
    Adv Exp Med Biol; 1995 Jul 15; 371B():905-8. PubMed ID: 7502923
    [No Abstract] [Full Text] [Related]

  • 38. The effects of aminosalicylic acid derivatives on nitric oxide in a cell-free system.
    Reynolds PD, Middleton SJ, Shorthouse M, Hunter JO.
    Aliment Pharmacol Ther; 1995 Oct 15; 9(5):491-5. PubMed ID: 8580268
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of prostaglandin biosynthesis by sulphasalazine and its metabolites.
    Collier HO, Francis AA, McDonald-Gibson WJ, Saeed SA.
    Prostaglandins; 1976 Feb 15; 11(2):219-25. PubMed ID: 4854
    [Abstract] [Full Text] [Related]

  • 40. Modulation of arachidonic acid metabolism by olsalazine and other aminosalicylates in leukocytes.
    Horn H, Preclik G, Stange EF, Ditschuneit H.
    Scand J Gastroenterol; 1991 Aug 15; 26(8):867-79. PubMed ID: 1685260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.